Ovid Therapeutics Inc.
USD2.72
+0.17 (+6.67%)
CEO
Margaret Alexander
IPO Date
2017-05-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.53
Prev. Close
$2.55
Day Low
$2.48
Day High
$2.73
52W Low
$0.30
52W High
$3.10
Market Cap
$0.36B
Volume
1.52M
| $0.00 |
| 9 Apr 2026 | PAPADOPOULOS STELIOS | director | A-Award | Acquired | 17,578 | $2.56 |
| 9 Apr 2026 | Friedman Bart | director | A-Award | Acquired | 8,789 | $2.56 |
| 9 Apr 2026 | Fitzgerald Kevin Joseph | director | A-Award | Acquired | 17,578 | $2.56 |
| 25 Mar 2026 | LEVIN JEREMY M | director, officer: Executive Chairman | M-Exempt | Acquired | 47,333 | $1.40 |
| 25 Mar 2026 | LEVIN JEREMY M | director, officer: Executive Chairman | M-Exempt | Disposed | 47,333 | $1.40 |
| 2 Mar 2026 | ALEXANDER MARGARET A. | director, officer: President and CEO | S-Sale | Disposed | 11,656 | $1.45 |
| 2 Mar 2026 | ALEXANDER MARGARET A. | director, officer: President and CEO | A-Award | Acquired | 1,435,000 | $1.65 |
| 2 Mar 2026 | PAPADOPOULOS STELIOS | director | A-Award | Acquired | 65,000 | $1.65 |